REQUEST A DEMO
Total
USD $0.00
Search more companies

Attest Research Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores | Specialty (except Psychiatric and Substance Abuse) Hospitals
Full name: Attest Research Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Research and development of pharmaceutical products including formulation development; technology transfer and stability study of drug products. to carry on the business of institutions of clinical research and establish research centre or hospital.

Headquarters
Chemor Plant 56442, (7.5 Miles) Jalan Ipoh/Chemor
Chemor; Perak; Postal Code: 31200

Contact Details: Purchase the Attest Research Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Attest Research Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Attest Research Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Attest Research Sdn. Bhd. report to view the information.
Incorporation Date:
January 28, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Attest Research Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.8%
Total operating revenue
-11.8%
Operating profit (EBIT)
-59.38%
EBITDA
-47.08%
Net Profit (Loss) for the Period
-69.08%
Total assets
5.97%
Total equity
4.72%
Operating Profit Margin (ROS)
-10.39%
Net Profit Margin
-10.34%
Return on Equity (ROE)
-10.75%
Debt to Equity Ratio
-4.8%
Quick Ratio
-0.28%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?